Get the Stockscreener App
5.40
15.62%
-1.00
Icecure Medical Ltd stock is traded at $5.40, with a volume of 5.23M.
It is down -15.62% in the last 24 hours and down -18.18% over the past month.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
See More
Previous Close:
$6.40
Open:
$6.51
24h Volume:
5.23M
Relative Volume:
2.15
Market Cap:
$15.16M
Revenue:
$3.57M
Net Income/Loss:
$-15.74M
P/E Ratio:
-0.7772
EPS:
-6.9481
Net Cash Flow:
$-15.77M
1W Performance:
+101.49%
1M Performance:
-18.18%
6M Performance:
-72.92%
1Y Performance:
-81.05%
1-Day Range:
$4.85
$6.79
1-Week Range:
$2.12
$9.54
52-Week Range:
$2.12
$42.00
Icecure Medical Ltd Stock (ICCM) Company Profile
Compare ICCM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
5.40 | 15.16M | 3.57M | -15.74M | -15.77M | -6.9481 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Icecure Medical Ltd Stock (ICCM) Latest News
IceCure Medical (ICCM) prices $5.5M private placement with warrant package - Stock Titan
IceCure Medical gains after ProSense update, $5.5M placement - TechStock²
IceCure announces pricing of private placement - Medical Buyer
Tumour freezing specialist IceCure Medical skyrockets from latest successes - Mugglehead Investment Magazine
Icecure Medical Ltd (ICCM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Icecure Medical Ltd (ICCM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Icecure Medical Ltd (ICCM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Icecure Medical Ltd (ICCM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Icecure Medical Ltd (ICCM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Icecure Medical Ltd (ICCM) Institutional Confidence - TradingKey
Icecure Medical Ltd (ICCM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Icecure Medical Ltd (ICCM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ICCM Stock Price, Quote & Chart - ChartMill
BIRD, NBIS, ICCM, HOOD, META: 5 Trending Stocks TodayRobinhood Markets (NASDAQ:HOOD) - Benzinga
IceCure Medical Ltd announced that it has received $5.499819 million in funding - marketscreener.com
IceCure Medical (ICCM) Sees Significant Growth in ProSense Insta - GuruFocus
IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor - PR Newswire
IceCure Medical (ICCM) Sees 70% Surge in Cryoablation Install Ba - GuruFocus
IceCure Stock Surges After 70% ProSense Install Increase - Benzinga
ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally? - TradingView
Stock Gains on News of 70% Surge in U.S. ProSense Install Base Fuels IceCure's (NASDAQ: ICCM) Breast Cancer Treatment Momentum - Investorideas.com
IceCure Medical jumps on U.S. ProSense install base growth after FDA clearance - TechStock²
IceCure Medical surges after update on U.S. ProSense adoption following FDA breast-cancer authorization - Quiver Quantitative
2 Stocks To Watch Today: ICCM, OCUL - RTTNews
ICCM Stock Explodes As New Cancer Data Fuels Trading Frenzy - StocksToTrade
Why is IceCure Medical stock surging today? By Investing.com - Investing.com South Africa
ICCM Stock Draws Traders As ProSense Data Impresses - timothysykes.com
Why is IceCure Medical stock surging today? - Investing.com
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance - StreetInsider
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance - Benzinga
IceCure Medical Ltd announced that it expects to receive $5.499819 million in funding - marketscreener.com
IceCure Medical (ICCM) Falls Over 11%: Key Support Levels Tested After Sharp DeclineCall Resistance - newsline.com
Icecure Medical Analyst Ratings and Price Targets | NASDAQ:ICCM - Benzinga
IceCure Medical to boost share price with 1-for-30 reverse split to regain NASDAQ compliance - MSN
IceCure Medical announces reverse share split - Medical Buyer
IceCure Medical (ICCM) Announces 1-for-30 Reverse Stock Split to Meet Nasdaq Requirements - GuruFocus
IceCure Medical: Split Part of Co's Proactive Efforts to Regain Compliance With Nasdaq $1 Minimum Bid Price Requirement and Support Co's Broader Cap Markets Strategy >ICCM - Moomoo
IceCure Medical (ICCM) Announces 1-for-30 Reverse Stock Split to Maintain Nasdaq Listing - GuruFocus
IceCure Medical Announces 1-for-30 Reverse Share Split to Maintain Nasdaq Listing - geneonline.com
IceCure Stock Drops Before The Bell As Nasdaq’s $1 Clock Ticks - Bez Kabli
IceCure Medical (NASDAQ: ICCM) implements 1-for-30 reverse share split for Nasdaq - Stock Titan
IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance - PR Newswire
IceCure consolidates shares 30-to-1 in bid to keep Nasdaq listing - Stock Titan
Why Has IceCure Medical's Stock Price Collapsed - Kavout
Number of shareholders of IceCure Medical Ltd. – BOATS:ICCM - TradingView
IceCure Medical (ICCM) Retreats Toward Support After 4% DeclineFair Value Gap - newsline.com
IceCure Medical (ICCM) Edges Higher as Stock Tests Key Resistance Near $0.24Advance Decline Volume - The Legal Advocate
Icecure Medical Earnings Call Highlights Growth Momentum - The Globe and Mail
Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ... By GuruFocus - Investing.com Canada
Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Rob - GuruFocus
IceCure Medical presents positive ProSense cryoablation data - grafa.com
Icecure Medical Ltd Stock (ICCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):